Abstract
Transplantation of haemopoietic stem cells (HSC) has cured thousands of children and adults with life-threatening malignant and nonmalignant diseases. Today, HSC are most commonly obtained from bone marrow, hematopoietic growth factor mobilized peripheral blood, or umbilical cord blood either from the patient themselves, or from an HLA-matched or mismatched related donor, unrelated adult volunteer donor, or from banked unrelated umbilical cord blood. Each stem cell source has well-defined advantages and disadvantages. This chapter reviews the key advances made in the field of HSC transplantation, the current application, complications, and limitations of this technology and postulates how HSC therapies may evolve in future years.
| Original language | English (US) |
|---|---|
| Title of host publication | Tissue and Cell Clinical Use |
| Subtitle of host publication | An Essential Guide |
| Publisher | Wiley-Blackwell |
| Pages | 312-331 |
| Number of pages | 20 |
| ISBN (Print) | 9781405198257 |
| DOIs | |
| State | Published - Aug 2 2012 |
Keywords
- Allogeneic
- Autologous
- Haemopoietic stem cell transplantation
- Haploidentical
- Umbilical cord blood